Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 295
8
Diseases
50
Unique genes
0.080
Avg. similarity score
Mitochondrial myopathy
Most-connected disease (5 links)
Disease
Searched: Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome
Mitochondrial myopathy
Progressive external ophthalmoplegia
Mitochondrial dna depletion syndrome
Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 3
Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 4
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression
Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy
Member diseases (most connected first ‐ the cluster's core)
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TK2 | 4 / 8 | Mitochondrial dna depletion syndrome, Mitochondrial myopathy, Progressive external ophthalmoplegia, Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 3 |
| POLG2 | 3 / 8 | Mitochondrial dna depletion syndrome, Progressive external ophthalmoplegia, Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 4 |
| RRM2B | 3 / 8 | Mitochondrial dna depletion syndrome, Mitochondrial myopathy, Progressive external ophthalmoplegia |
| SLC25A4 | 3 / 8 | Mitochondrial dna depletion syndrome, Mitochondrial myopathy, Progressive external ophthalmoplegia |
| FDX2 | 2 / 8 | Mitochondrial myopathy, Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy |
| IL1A | 2 / 8 | Mitochondrial myopathy, Progressive external ophthalmoplegia |
| IL1B | 2 / 8 | Mitochondrial myopathy, Progressive external ophthalmoplegia |
| MSTO1 | 2 / 8 | Mitochondrial myopathy, Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome |
| POLG | 2 / 8 | Mitochondrial dna depletion syndrome, Progressive external ophthalmoplegia |
| RRM1 | 2 / 8 | Mitochondrial dna depletion syndrome, Progressive external ophthalmoplegia |
| SLC25A42 | 2 / 8 | Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, Mitochondrial myopathy |
| TWNK | 2 / 8 | Mitochondrial dna depletion syndrome, Progressive external ophthalmoplegia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Nucleotide metabolism | KEGG | 7 / 85 | 19.8× | 5.41e-8 | 3.26e-6 ✓ sig. |
| Transcriptional activation of mitochondrial biogenesis | Reactome | 5 / 51 | 23.5× | 2.07e-6 | 7.79e-5 ✓ sig. |
| Pyrimidine metabolism | KEGG | 5 / 58 | 20.7× | 3.95e-6 | 1.35e-4 ✓ sig. |
| Interconversion of nucleotide di- and triphosphates | Reactome | 4 / 29 | 33.1× | 5.85e-6 | 1.87e-4 ✓ sig. |
| Prion disease | KEGG | 8 / 275 | 7.0× | 1.59e-5 | 4.31e-4 ✓ sig. |
| Graft-versus-host disease | KEGG | 4 / 45 | 21.4× | 3.49e-5 | 8.21e-4 ✓ sig. |
| Interleukin-10 signaling | Reactome | 4 / 47 | 20.4× | 4.16e-5 | 9.44e-4 ✓ sig. |
| Mitochondrial transcription initiation | Reactome | 2 / 3 | 160× | 5.08e-5 | 1.11e-3 ✓ sig. |
| Influenza A | KEGG | 6 / 173 | 8.3× | 7.70e-5 | 1.54e-3 ✓ sig. |
| Inflammatory bowel disease | KEGG | 4 / 66 | 14.6× | 1.58e-4 | 2.73e-3 ✓ sig. |
| Antifolate resistance | KEGG | 3 / 30 | 24.0× | 2.55e-4 | 3.97e-3 ✓ sig. |
| Pertussis | KEGG | 4 / 78 | 12.3× | 3.02e-4 | 4.53e-3 ✓ sig. |
| Propanoate metabolism | KEGG | 3 / 32 | 22.5× | 3.09e-4 | 4.61e-3 ✓ sig. |
| Drug metabolism - other enzymes | KEGG | 4 / 81 | 11.9× | 3.49e-4 | 5.06e-3 ✓ sig. |
| Interleukin-1 processing | Reactome | 2 / 8 | 60.1× | 4.68e-4 | 6.35e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| mitochondrial DNA replication | GO:0006264 | 8 / 11 | 272× | 2.39e-19 | 3.46e-16 ✓ sig. |
| vascular endothelial growth factor production | GO:0010573 | 3 / 6 | 187× | 3.58e-7 | 3.68e-5 ✓ sig. |
| mitochondrial DNA repair | GO:0043504 | 3 / 7 | 160× | 6.26e-7 | 5.86e-5 ✓ sig. |
| mitochondrial transcription | GO:0006390 | 3 / 8 | 140× | 1.00e-6 | 8.59e-5 ✓ sig. |
| mitochondrion organization | GO:0007005 | 6 / 130 | 17.2× | 1.25e-6 | 1.03e-4 ✓ sig. |
| DNA biosynthetic process | GO:0071897 | 4 / 32 | 46.7× | 1.54e-6 | 1.23e-4 ✓ sig. |
| response to copper ion | GO:0046688 | 3 / 12 | 93.4× | 3.90e-6 | 2.59e-4 ✓ sig. |
| pyrimidine nucleobase metabolic process | GO:0006206 | 2 / 2 | 374× | 7.02e-6 | 4.13e-4 ✓ sig. |
| positive regulation of neuroinflammatory response | GO:0150078 | 3 / 16 | 70.1× | 9.85e-6 | 5.38e-4 ✓ sig. |
| response to activity | GO:0014823 | 4 / 52 | 28.7× | 1.12e-5 | 5.93e-4 ✓ sig. |
| ectopic germ cell programmed cell death | GO:0035234 | 3 / 18 | 62.3× | 1.43e-5 | 7.18e-4 ✓ sig. |
| carbohydrate derivative metabolic process | GO:1901135 | 3 / 18 | 62.3× | 1.43e-5 | 7.18e-4 ✓ sig. |
| DNA repair | GO:0006281 | 8 / 420 | 7.1× | 1.43e-5 | 7.18e-4 ✓ sig. |
| ribonucleoside diphosphate metabolic process | GO:0009185 | 2 / 3 | 249× | 2.10e-5 | 9.61e-4 ✓ sig. |
| deoxyribonucleotide biosynthetic process | GO:0009263 | 2 / 3 | 249× | 2.10e-5 | 9.61e-4 ✓ sig. |